14-day Premium Trial Subscription Try For FreeTry Free

Explanation to Bollinger's Bands

Bollinger Bands was created by John Bollinger in the early 1980s, its purpose is to define price action relative to the assets highs and lows. This technical indicator is used to identify buy and sell signals and has proven very well in doing so.

Bollinger Bands consist of a set of three curves drawn in relation to securities prices. The middle band is a measure of the intermediate-term trend, usually a simple moving average, that serves as the base for the upper and lower bands. The interval between the upper and lower bands and the middle band is determined by volatility, typically the standard deviation of the same data that were used for the average. StockInvest.us uses Bollingers suggested 20 day average.

Middle Bollinger Band = 20-period simple moving average
Upper Bollinger Band = Middle Bollinger Band + 2 * 20-period standard deviation
Lower Bollinger Band = Middle Bollinger Band - 2 * 20-period standard deviation

BandWidth defines the current width of the band.
%b defines the current position within the band.

BandWidth = (Upper Bollinger Band - Lower Bollinger Band) / Middle Bollinger Band
%b = (Last - Lower Bollinger Band) / (Upper Bollinger Band - Lower Bollinger Band)

Live Samples:

Bollinger Bottleneck Buy Pattern 1
Bollinger Bottleneck Buy Pattern 2
Bollinger Bottleneck Sell Pattern

Bottlenecks in bandwidth indicate an upcoming change. Break up through the moving average line or continuous movements above the moving average line indicate a break up, and vice versa.

Source: http://www.bollingerbands.com

RSI low/high Values: [ 25 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of VIRI
Powered by GPT-4
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

High volatility in Virios Therapeutics, LLC stock price on Thursday which ended trading at $0.421
(Updated on May 02, 2024)

Sell candidate since May 02, 2024 PDF

The Virios Therapeutics, LLC stock price fell by -4.27% on the last day (Thursday, 2nd May 2024) from $0.440 to $0.421. It has now fallen 3 days in a row. During the last trading day the stock fluctuated 12.19% from a day low at $0.401 to a day high of $0.450. The price has fallen in 6 of the last 10 days and is down by -6.4% for this period. Volume has increased on the last day by 106 thousand shares but on falling prices. This may be an early warning and the risk will be increased slightly over the next couple of days. In total, 129 thousand shares were bought and sold for approximately $54.22 thousand.

The stock lies in the lower part of a very wide and strong rising trend in the short term, and this may normally pose a very good buying opportunity. If the lower trend floor at $0.380 is broken, it will firstly indicate a slower rate of rising, but may also be an early warning for a trend shift. Given the current short-term trend, the stock is expected to rise 22.69% during the next 3 months and, with a 90% probability hold a price between $0.466 and $0.765 at the end of this 3-month period.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

VIRI Signals & Forecast

There are few to no technical positive signals at the moment. The Virios Therapeutics, LLC stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. On corrections up, there will be some resistance from the lines at $0.448 and $0.443. A break-up above any of these levels will issue buy signals. A sell signal was issued from a pivot top point on Monday, April 01, 2024, and so far it has fallen -27.40%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Virios Therapeutics, LLC gained volume on the last day, but on falling prices. In technical terms, this is called divergence and may be an early warning. In some cases, increasing volume on falling prices may be considered positive, but that is mainly in typical "sell-offs". The very low volume increases the risk and reduces the other technical signals issued.

Support, Risk & Stop-loss for Virios Therapeutics, LLC stock

On the downside, the stock finds support just below today's level from accumulated volume at $0.354 and $0.332. There is a natural risk involved when a stock is testing a support level, since if this is broken, the stock then may fall to the next support level. In this case, Virios Therapeutics, LLC finds support just below today's level at $0.354. If this is broken, then the next support from accumulated volume will be at $0.332 and $0.330.

This stock has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the stock moved $0.0489 between high and low, or 12.19%. For the last week, the stock has had daily average volatility of 6.94%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (VIRI) For The Upcoming Trading Day Of Friday 3rd

For the upcoming trading day on Friday, 3rd we expect Virios Therapeutics, LLC to open at $0.424, and during the day (based on 14 day Average True Range), to move between $0.373 and $0.469, which gives a possible trading interval of +/-$0.0478 (+/-11.35%) up or down from last closing price. If Virios Therapeutics, LLC takes out the full calculated possible swing range there will be an estimated 22.70% move between the lowest and the highest trading price during the day.

Since the stock is closer to the resistance from accumulated volume at $0.430 (2.14%) than the support at $0.354 (15.93%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.

Earnings coming up

Virios Therapeutics, LLC will release earnings BMO on Thursday, May 09, 2024.The consensus among the analysts for the expected earnings (EPS) is -$0.0800. We will update the financials statements for Virios Therapeutics, LLC, that can be found here as soon as the records are public. Our systems has calculated a possible swing of +/- 20.03% in the first trading day after earnings release.

Is Virios Therapeutics, LLC stock A Buy?

The Virios Therapeutics, LLC stock holds several negative signals and despite the positive trend, we believe Virios Therapeutics, LLC will perform weakly in the next couple of days or weeks. Therefore, we hold a negative evaluation of this stock. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Buy to a Strong Sell candidate.

Current score: -5.005 Strong Sell Candidate Downgraded

Predicted Opening Price for Virios Therapeutics, LLC of Friday, May 3, 2024

Fair opening price May 3, 2024 Current price
$0.424 ( 0.705%) $0.421

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for VIRI

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 0.473 12.32 %
R2 0.454 7.88 %
R1 0.443 5.14 %
Current price: 0.421
Support S1 0.405 -3.73 %
S2 0.394 -6.47 %
S3 0.375 -10.91 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 0.470 11.56 %
R2 0.457 8.62 %
R1 0.430 2.14 %
Current price 0.421
Support S1 0.354 -15.93%
S2 0.332 -21.16%
S3 0.330 -21.71%

FAQ

What is the symbol for Virios Therapeutics, LLC Stock and on which exchange is it traded?
The symbol for Virios Therapeutics, LLC is VIRI and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Virios Therapeutics, LLC Stock?
The Virios Therapeutics, LLC stock holds several negative signals and despite the positive trend, we believe Virios Therapeutics, LLC will perform weakly in the next couple of days or weeks. Therefore, we hold a negative evaluation of this stock. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Buy to a Strong Sell candidate.

How to buy Virios Therapeutics, LLC Stock?
Virios Therapeutics, LLC Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Virios Therapeutics, LLC Stock.

What's the current price of Virios Therapeutics, LLC Stock?
As of the end of day on the May 02, 2024, the price of an Virios Therapeutics, LLC (VIRI) share was $0.421.

What is the 52-week high and low for Virios Therapeutics, LLC Stock?
The 52-week high for Virios Therapeutics, LLC Stock is $2.42 and the 52-week low is $0.280.

What is the market capitalization of Virios Therapeutics, LLC Stock?
As of the May 02, 2024, the market capitalization of Virios Therapeutics, LLC is 8.472M.

When is the next earnings date for Virios Therapeutics, LLC?
The upcoming earnings date for Virios Therapeutics, LLC is May 09, 2024.
Click to get the best stock tips daily for free!

About Virios Therapeutics, LLC

Virios Therapeutics LLC Virios Therapeutics, Inc., a development-stage biotechnology company, focuses on developing antiviral therapies to treat diseases associated with a viral triggered abnormal immune response. The company's lead development candidate is the IMC-1, a fixed dose combination of famciclovir and celecoxib to treat fibromyalgia. It is also developing IMC-2, a combination of valacyclovir and celecoxib for the treatment of managing the fatigue, sleep, atten... VIRI Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT